Rainbow Children’s Medicare Limited has announced its financial results for the quarter and year ended March 31, 2026. The company reported robust growth, with a consolidated revenue of ₹17,030.77 million for the fiscal year. In addition to the strong performance, the Board of Directors has recommended a final dividend of ₹3.50 per share for the financial year. The company also confirmed key leadership re-appointments and strategic updates for the coming year.
Financial Highlights
For the financial year ended March 31, 2026, the company achieved a consolidated net profit of ₹2,815.44 million, reflecting significant growth compared to the previous fiscal year. Total revenue for the year stood at ₹17,030.77 million. On a quarterly basis, the company reported a consolidated revenue of ₹4,599.01 million for the fourth quarter.
Dividend Recommendation
The Board of Directors has recommended a final dividend of ₹3.50 per share (a 35% payout on the face value of ₹10) for the financial year ended March 31, 2026. The payout is subject to approval by shareholders at the 28th Annual General Meeting scheduled for July 29, 2026. The record date for the dividend and the AGM is fixed for July 21, 2026.
Leadership and Governance
The Board has approved the re-appointment of key leadership figures to ensure continued strategic direction. Dr. Ramesh Kancharla has been re-appointed as Chairman and Managing Director, and Dr. Dinesh Kumar Chirla as Whole Time Director, both for a new five-year term effective from August 11, 2026. Additionally, the Board re-appointed Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati as Independent Directors for second terms.
Strategic Developments
The company continued its expansion strategy during the year, including the acquisition of Prashanthi Medicare Private Limited and Pratiksha Women & Child Care Hospital Private Limited. These acquisitions have been successfully integrated, contributing to the overall revenue growth. Furthermore, the company has implemented the ESOP 2025 scheme, granting 267,550 stock options to eligible employees to further align performance with shareholder value.
Source: BSE
